US customs raids find thousands of fake COVID-19 test kits
05-05-2020
US companies hit hardest by fake medicines: EUIPO, OECD
24-03-2020
Kira Yan / Shutterstock.com
The COVID-19 pandemic is heightening the dangers posed by the global trade in counterfeit pharmaceutical products, according to the Organisation for Economic Co-operation and Development (OECD) and the European Union Intellectual Property Office (EUIPO).
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
COVID-19, coronavirus, pandemic, EUIPO, OECD, counterfeit medicines, counterfeit trade, drugs, trade, pharmaceutical products,
